Protein folding is a critical biological process where proteins adopt their functional conformations after synthesis. Recent advances in experimental and theoretical approaches have revealed that folding is a stochastic process, biased by the stability of native-like interactions. Natural protein sequences evolve to efficiently fold into their native states in complex cellular environments. However, under certain conditions, proteins may misfold or remain misfolded, leading to diseases such as amyloidoses, which involve the deposition of aggregated proteins. These diseases are intriguing because amyloid aggregates are not typically found in functional biological systems, suggesting evolutionary mechanisms to prevent their formation. Understanding these mechanisms is crucial for developing strategies to prevent and treat amyloid-related diseases. Protein folding involves the formation of a unique conformation from a disordered state, a process that can be modeled using energy landscapes. The Levinthal paradox highlights the challenge of finding the correct conformation, but the energy landscape model explains how proteins can fold rapidly due to the stability of native-like interactions. Theoretical simulations and experimental techniques, such as NMR and circular dichroism, have provided insights into the folding process and the role of intermediate states. Misfolding can lead to aggregation, which is a common feature of many diseases, including Alzheimer's and prion diseases. Amyloid fibrils, characterized by their β-sheet structure, are found in various diseases and are similar across different proteins. The formation of amyloid fibrils can be influenced by mutations that destabilize the native state, leading to the accumulation of partially folded intermediates. These intermediates can aggregate, forming fibrils that are resistant to degradation. The study of lysozyme and other proteins has shown that amyloid formation is a generic property of polypeptides, not limited to disease-associated proteins. The ability to form amyloid fibrils is influenced by the physicochemical properties of the polypeptide chain and the stability of the native state. The evolution of proteins has favored sequences that fold into compact, soluble structures that resist aggregation. However, mutations can disrupt this balance, leading to the formation of amyloid fibrils. The development of molecular chaperones and other quality control mechanisms helps prevent misfolding and aggregation. The study of amyloid formation provides insights into the broader mechanisms of protein folding and misfolding, with implications for understanding and treating a wide range of diseases. The structural properties of amyloid fibrils also suggest potential applications in nanotechnology, highlighting the importance of understanding protein folding and aggregation in both biological and technological contexts.Protein folding is a critical biological process where proteins adopt their functional conformations after synthesis. Recent advances in experimental and theoretical approaches have revealed that folding is a stochastic process, biased by the stability of native-like interactions. Natural protein sequences evolve to efficiently fold into their native states in complex cellular environments. However, under certain conditions, proteins may misfold or remain misfolded, leading to diseases such as amyloidoses, which involve the deposition of aggregated proteins. These diseases are intriguing because amyloid aggregates are not typically found in functional biological systems, suggesting evolutionary mechanisms to prevent their formation. Understanding these mechanisms is crucial for developing strategies to prevent and treat amyloid-related diseases. Protein folding involves the formation of a unique conformation from a disordered state, a process that can be modeled using energy landscapes. The Levinthal paradox highlights the challenge of finding the correct conformation, but the energy landscape model explains how proteins can fold rapidly due to the stability of native-like interactions. Theoretical simulations and experimental techniques, such as NMR and circular dichroism, have provided insights into the folding process and the role of intermediate states. Misfolding can lead to aggregation, which is a common feature of many diseases, including Alzheimer's and prion diseases. Amyloid fibrils, characterized by their β-sheet structure, are found in various diseases and are similar across different proteins. The formation of amyloid fibrils can be influenced by mutations that destabilize the native state, leading to the accumulation of partially folded intermediates. These intermediates can aggregate, forming fibrils that are resistant to degradation. The study of lysozyme and other proteins has shown that amyloid formation is a generic property of polypeptides, not limited to disease-associated proteins. The ability to form amyloid fibrils is influenced by the physicochemical properties of the polypeptide chain and the stability of the native state. The evolution of proteins has favored sequences that fold into compact, soluble structures that resist aggregation. However, mutations can disrupt this balance, leading to the formation of amyloid fibrils. The development of molecular chaperones and other quality control mechanisms helps prevent misfolding and aggregation. The study of amyloid formation provides insights into the broader mechanisms of protein folding and misfolding, with implications for understanding and treating a wide range of diseases. The structural properties of amyloid fibrils also suggest potential applications in nanotechnology, highlighting the importance of understanding protein folding and aggregation in both biological and technological contexts.